Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Slight Risk of Interstitial Lung Disease Seen With Certain DOACs

News Daily News

Slight Risk of Interstitial Lung Disease Seen With Certain DOACs

November 23, 2022

April 2021 News Roundup

News Opinion CV Team Dispatch

April 2021 News Roundup

April 10, 2021

CV Complications of Malaria Rare but Portend Poor Prognosis

News Daily News

CV Complications of Malaria Rare but Portend Poor Prognosis

Michael O'Riordan

February 22, 2021

Arrhythmias in COVID-19: New Review Tackles Mechanisms, Management

News Daily News

Arrhythmias in COVID-19: New Review Tackles Mechanisms, Management

August 13, 2020

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

News Daily News

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Michael O'Riordan

July 13, 2020

Dose of Reality? Hydroxychloroquine and Chloroquine Again Disappoint in COVID-19

News Daily News

Dose of Reality? Hydroxychloroquine and Chloroquine Again Disappoint in COVID-19

Michael O'Riordan

May 26, 2020

Choosing a DOAC? Apixaban May Have an Edge Over Rivaroxaban

News Daily News

Choosing a DOAC? Apixaban May Have an Edge Over Rivaroxaban

March 09, 2020

DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus

News Daily News

DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus

October 04, 2018

No Increased Risk of Serious Liver Injury Seen With NOACs

News Daily News

No Increased Risk of Serious Liver Injury Seen With NOACs

March 13, 2018

One in Five CABG Patients Develop New-Onset Atrial Fibrillation: EXCEL

News Daily News

One in Five CABG Patients Develop New-Onset Atrial Fibrillation: EXCEL

Michael O'Riordan

February 12, 2018

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

News Conference News TCT 2017

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

November 02, 2017

Dabigatran Reversal Agent Yields No Surprises in Final RE-VERSE AD Study Results

News Daily News

Dabigatran Reversal Agent Yields No Surprises in Final RE-VERSE AD Study Results

July 14, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.